BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang W, Hu JW, He XR, Jin WL, He XY. Statins: a repurposed drug to fight cancer. J Exp Clin Cancer Res 2021;40:241. [PMID: 34303383 DOI: 10.1186/s13046-021-02041-2] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
Number Citing Articles
1 Beton K, Brożek-Płuska B. Biochemistry and Nanomechanical Properties of Human Colon Cells upon Simvastatin, Lovastatin, and Mevastatin Supplementations: Raman Imaging and AFM Studies. J Phys Chem B 2022. [PMID: 36083294 DOI: 10.1021/acs.jpcb.2c03724] [Reference Citation Analysis]
2 Kortüm B, Radhakrishnan H, Zincke F, Sachse C, Burock S, Keilholz U, Dahlmann M, Walther W, Dittmar G, Kobelt D, Stein U. Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis. Oncogene 2022. [PMID: 36008464 DOI: 10.1038/s41388-022-02407-6] [Reference Citation Analysis]
3 Boswell L, Serés-Noriega T, Mesa A, Perea V, Pané A, Viñals C, Blanco J, Giménez M, Vinagre I, Esmatjes E, Conget I, Amor AJ. Carotid ultrasonography as a strategy to optimize cardiovascular risk management in type 1 diabetes: a cohort study. Acta Diabetol 2022. [PMID: 36006487 DOI: 10.1007/s00592-022-01959-z] [Reference Citation Analysis]
4 Lou D, Fu R, Gu L, Su H, Guan L. Association between statins exposure with incidence and prognosis of gastric cancer: an updated meta-analysis. Expert Rev Clin Pharmacol 2022. [PMID: 35947078 DOI: 10.1080/17512433.2022.2112178] [Reference Citation Analysis]
5 Li Y, Zhou H, Zou L, Scicchitano P. Influence of Statins on the Survival Outcomes of Patients with Diffuse Large B Cell Lymphoma: A Systematic Review and Meta-Analysis. International Journal of Clinical Practice 2022;2022:1-9. [DOI: 10.1155/2022/5618290] [Reference Citation Analysis]
6 Jiang M, Wu X, Bao S, Wang X, Qu F, Liu Q, Huang X, Li W, Tang J, Yin Y. Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancer. Front Immunol 2022;13:946468. [DOI: 10.3389/fimmu.2022.946468] [Reference Citation Analysis]
7 Pereira M, Matuszewska K, Glogova A, Petrik J. Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy. Cancers 2022;14:3500. [DOI: 10.3390/cancers14143500] [Reference Citation Analysis]
8 Yang C, Fan S, Wang X, Liu W, Yang L, He B, Dai W, Zhang H, Wang X, Zhang Q. Optimize the combination regimen of Trastuzumab and Nab-paclitaxel in HER2-positive tumors via modulating Caveolin-1 expression by lovastatin. Asian Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ajps.2022.06.002] [Reference Citation Analysis]
9 Lo Sardo F, Canu V, Maugeri-Saccà M, Strano S, Blandino G. YAP and TAZ: Monocorial and bicorial transcriptional co-activators in human cancers. Biochim Biophys Acta Rev Cancer 2022;1877:188756. [PMID: 35777600 DOI: 10.1016/j.bbcan.2022.188756] [Reference Citation Analysis]
10 Zhao R, Ning X, Wang M, Wang H, Xing G, Wang L, Lu C, Yu A, Wang Y. A ROS-Responsive Simvastatin Nano-Prodrug and its Fibronectin-Targeted Co-Delivery System for Atherosclerosis Treatment. ACS Appl Mater Interfaces 2022;14:25080-92. [PMID: 35618653 DOI: 10.1021/acsami.2c02354] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tsai C, Changchien C, Chen Y, Lai C, Chen T, Chang H, Tsai W, Tsai Y, Tsai H, Lin H, Wang C, Shen M, Lin Y. Survival Benefit of Statin with Anti-Angiogenesis Efficacy in Lung Cancer-Associated Pleural Fluid through FXR Modulation. Cancers 2022;14:2765. [DOI: 10.3390/cancers14112765] [Reference Citation Analysis]
12 Abdelsayed M, Kort EJ, Jovinge S, Mercola M. Repurposing drugs to treat cardiovascular disease in the era of precision medicine. Nat Rev Cardiol. [DOI: 10.1038/s41569-022-00717-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Marcianò G, Palleria C, Casarella A, Rania V, Basile E, Catarisano L, Vocca C, Bianco L, Pelaia C, Cione E, D’agostino B, Citraro R, De Sarro G, Gallelli L. Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role. Pharmaceuticals 2022;15:589. [DOI: 10.3390/ph15050589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Xia Y, Jin Y, Cui D, Wu X, Song C, Jin W, Huang H. Antitumor Effect of Simvastatin in Combination With DNA Methyltransferase Inhibitor on Gastric Cancer via GSDME-Mediated Pyroptosis. Front Pharmacol 2022;13:860546. [DOI: 10.3389/fphar.2022.860546] [Reference Citation Analysis]
15 Sheridan A, Wheeler-jones CPD, Gage MC. The Immunomodulatory Effects of Statins on Macrophages. Immuno 2022;2:317-43. [DOI: 10.3390/immuno2020021] [Reference Citation Analysis]
16 Brailovski E, Li Q, Liu N, Leber B, Khalaf D, Sabloff M, Christou G, Yee K, Chodirker L, Parmentier A, Siddiqui M, Mamedov A, Zhang L, Liu Y, Earle CC, Cheung MC, Mittmann N, Buckstein RJ, Mozessohn L. The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes. Ann Hematol 2022. [PMID: 35190844 DOI: 10.1007/s00277-022-04802-1] [Reference Citation Analysis]
17 Morofuji Y, Nakagawa S, Ujifuku K, Fujimoto T, Otsuka K, Niwa M, Tsutsumi K. Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer. Pharmaceuticals 2022;15:151. [DOI: 10.3390/ph15020151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Tanase C, Enciu AM, Codrici E, Popescu ID, Dudau M, Dobri AM, Pop S, Mihai S, Gheorghișan-Gălățeanu AA, Hinescu ME. Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and/or Separately? Int J Mol Sci 2022;23:604. [PMID: 35054787 DOI: 10.3390/ijms23020604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Elakkad YE, Mohamed SNS, Abuelezz NZ. Potentiating the Cytotoxic Activity of a Novel Simvastatin-Loaded Cubosome against Breast Cancer Cells: Insights on Dual Cell Death via Ferroptosis and Apoptosis. Breast Cancer (Dove Med Press) 2021;13:675-89. [PMID: 34934357 DOI: 10.2147/BCTT.S336712] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Staszczak M. Fungal Secondary Metabolites as Inhibitors of the Ubiquitin-Proteasome System. Int J Mol Sci 2021;22:13309. [PMID: 34948102 DOI: 10.3390/ijms222413309] [Reference Citation Analysis]
21 Grabarek BO, Boroń D, Morawiec E, Michalski P, Palazzo-Michalska V, Pach Ł, Dziuk B, Świder M, Zmarzły N. Crosstalk between Statins and Cancer Prevention and Therapy: An Update. Pharmaceuticals (Basel) 2021;14:1220. [PMID: 34959621 DOI: 10.3390/ph14121220] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
22 Mangelinck A, Habel N, Mohr A, Gaspar N, Stefanovska B, Fromigué O. Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma. Cancers (Basel) 2021;13:5869. [PMID: 34831022 DOI: 10.3390/cancers13225869] [Reference Citation Analysis]
23 Meng X, Gao JZ, Gomendoza SMT, Li JW, Yang S. Recent Advances of WEE1 Inhibitors and Statins in Cancers With p53 Mutations. Front Med (Lausanne) 2021;8:737951. [PMID: 34671620 DOI: 10.3389/fmed.2021.737951] [Cited by in F6Publishing: 1] [Reference Citation Analysis]